3GUIMBAUD R,GUICHARD S,DUSSEAU C,et al. Dihy-dropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humans [ J ]. Cancer Chemother Pharmacol,2000,45:477.
5XIONG HQ, AJANI JA. Treatment of colorectal cancer metastasis: the role of chemotherapy [ J ]. Cancer Metastasis Rev, 2004,23 ( 1-2) :145.
6YASUHIDE Y, ATSUSHI O, NARIKAZU B, et al. Phase Ⅰ / Ⅱ Study of Oxaliplatin with Weekly Bolus Fluorouracil and High-Dose Leucovorin(ROX) As First-Line Therapy for Patients with Colorectal Cancer [ J ]. Japanese Journal of Clinical Oncology, 2006,36 ( 4 ) : 218.
8MALET-MARTINO M, MATRINO R. Clinical Studies of Three Oral Prodrugs of 5-Fluorouracil(Capecitabine,UFT,S-1 ) :A Review[J]. The oncologist,2002,7 (4) :288.
9WANG LW, YANG SH, LIN JK, et al. Pre-operative chemoradiotherapy with oral tegafur-uracil and elucovorin for rectal cancer [ J ]. J Surg Oncol,2005,89(4) :256.
10CHAO Y, LI CP, CHAO TY, et al. An open, multi-centre, phase Ⅱ clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer [ J ]. Br J Cancer,2006,95 ( 2 ) : 159.
3Jemal A,Bray F,Center MM,Ferlay J,Ward E,Forman D.Global cancer statistics.CA Cancer J Clin 2011;61:69-90.
4Benson AB.S-1:another oral agent for patients with colorectal cancer.Lancet Oncol 2013;14:1244-1245.
5Ohtsu A,Baba H,Sakata Y,Mitachi Y,Horikoshi N,Sugimachi K,Taguchi T.Phase II study of S-1,a novel oral fluorophyrimidine derivative,in patients with metastatic colorectal carcinoma.S-1 Cooperative Colorectal Carcinoma Study Group.Br J Cancer 2000;83:141-145.
6Goto A,Yamada Y,Yasui H,Kato K,Hamaguchi T,Muro K,Shimada Y,Shirao K.Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer.Ann Oncol 2006;17:968-973.
7Shiozawa M,Akaike M,Sugano N,Tsuchida K,Yamamoto N,Morinaga S.A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer.Cancer Chemother Pharmacol 2010;66:987-992.
8Ogata Y,Tanaka T,Akagi Y,Ishibashi N,Tsuji Y,Matono K,Isobe M,Sueyoshi S,Kaibara A,Shirouzu K.Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer.Clin Med Insights Oncol 2013;7:21-30.
9Yamada Y,Tahara M,Miya T,Satoh T,Shirao K,Shimada Y,Ohtsu A,Sasaki Y,Tanigawara Y.Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.Br J Cancer 2008;98:1034-1038.
10Ferlay J,Bray F,Parkin DM.Globocan 2012:Estimates Cancer Incidence,Mortality and Prevalence Wordwild in 2012.Available from:URL:http://globocan.iarc.fr/Default.aspx.
